Andrew Adams

Co-Founder & Managing Partner

Healthcare

"At Oak HC/FT, we’re passionate about deploying our collective skills to address important issues in the multi-trillion-dollar Healthcare and FinTech markets. We back innovative companies who are leveraging technology to improve quality, reduce inefficiencies and enhance customer experiences."

Active Investments

  • AllyAlign Health
  • August Bioservices
  • DispatchHealth
  • Everside Health
  • Galileo
  • Independent Living Systems
  • Noom
  • Precision Medicine Group
  • Rialtic
  • Sema4
  • Unified Women's Healthcare
  • US HealthVest
  • Veda
  • WithMe Health

Prior Investments

  • American Esoteric Laboratories (acquired by Sonic Healthcare Limited)
  • Argus Information & Advisory Services (acquired by Verisk Analytics)
  • Benefitfocus (NASDAQ: BNFT)
  • CareMedic Systems (acquired by Ingenix)
  • CLARiENT (NASDAQ: CLRT; acquired by GE Healthcare)
  • Core Informatics (acquired by Thermo Fisher Scientific)
  • Health Dialog (acquired by British United Provident Association)
  • iHealth Technologies (merged with Connolly)
  • LDI Integrated Pharmacy Services (acquired by Diplomat Pharmacy)
  • Limeade (ASX: LME)
  • Maestro Health (acquired by AXA Group)
  • NetSpend Corporation (NASDAQ: NTSP; acquired by TSYS)
  • PayFlex Systems (acquired by Aetna)
  • PharMEDium Healthcare (acquired by Clayton, Dubilier & Rice)
  • Therapy Brands (acquired by KKR)
  • United BioSource (acquired by Medco Health Solutions)
  • One Medical Group (NASDAQ: ONEM)

Andrew W. Adams (HC), is a Co-Founder and Managing Partner of Oak HC/FT where he focuses on growth equity and early-stage venture opportunities in Healthcare.

 

Andrew currently serves on the Boards of AllyAlign Health, August Bioservices, DispatchHealth, Everside Health, Galileo, Rialtic, Unified Women's Healthcare, US HealthVest, Veda and WithMe Health. Andrew is also actively involved with Independent Living Systems, Noom, Precision Medicine Group and Sema4.

 

Recent prior investments include Core Informatics (acquired by Thermo Fischer Scientific), LDI (acquired by Diplomat Pharmacy), Limeade (ASX: LME), Maestro Health (acquired by AXA Group), One Medical Group (NASDAQ:ONEM) and Therapy Brands (acquired by KKR). Other prior investments include American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), Benefitfocus (NASDAQ: BNFT), CareMedic Systems (acquired by Ingenix), CLARiENT (acquired by GE Healthcare), Health Dialog (acquired by British United Provident Association), iHealth Technologies (merged with Connolly), NetSpend Corporation (acquired by TSYS), PayFlex Systems (acquired by Aetna), PharMEDium Healthcare (acquired by CD&R) and United BioSource (acquired by Medco Health Solutions).

 

Andrew joined Oak Investment Partners in 2003 and prior to that was a Senior Associate with Capital Resource Partners, a mezzanine capital firm where he focused on investments in healthcare and business services companies. Andrew was also a Financial Analyst in the media and communications group of Deutsche Banc Alex. Brown.

 

Andrew received a Bachelor of Arts degree from Princeton University.

LIGHTNING ROUND WITH ANDREW

What is your spirit animal?

A tiger.

Dream vacation?

Any small, remote beach.

Go-to Karaoke song?

“Here I Go Again” by Whitesnake

What book have you read again and again?

“Shoe Dog: A Memoir by the Creator of Nike” by Phil Knight

Where were you born?

Alvin, Texas (home of Nolan Ryan)